Last Updated: Apr 08, 2016
- The association of soy food consumption with the risk of subtype of breast cancers defined by hormone receptor and HER2 status.
Baglia Michelle L, et al. International journal of cancer 2016 3 - BRCA1 Gene Mutation Screening for the Hereditary Breast and/or Ovarian Cancer Syndrome in Breast Cancer Cases: a First High Resolution DNA Melting Analysis in Indonesia.
Mundhofir Farmaditya Ep et al. Asian Pacific journal of cancer prevention : APJCP 2016 17(3) 1539-46 - Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients.
Marino Patricia et al. Breast cancer research and treatment 2011 Sep 129(2) 401-9 - Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
Dinan Michaela A et al. JAMA oncology 2015 May 1(2) 158-66 - Identifying Women at Risk for Hereditary Breast and Ovarian Cancer Syndrome Utilizing Breast Care Nurse Navigation at Mammography and Imaging Centers.
Appel Susan J et al. Journal of National Black Nurses' Association : JNBNA 2015 Dec 26(2) 17-26 - Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.
Riahi Aouatef et al. Breast cancer (Tokyo, Japan) 2016 Mar - Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
Bagheri Fatemeh, et al. Molecular medicine reports 2016 3 - Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations.
Yao Lu, et al. Breast cancer research and treatment 2016 3 - Comparative genomic analysis of primary tumors and metastases in breast cancer.
Bertucci François, et al. Oncotarget 2016 3 - Analysing the mutational status of adenomatous polyposis coli (APC) gene in breast cancer.
Chang Ya-Sian, et al. Cancer cell international 2016 0 23 - Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility.
Cybulski Cezary, et al. Nature genetics 2016 3 (4) 473 - GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease.
Liu Jingjing, et al. Cancer letters 2016 3 - Germline mutations of the DNA repair pathways in uterine serous carcinoma.
Frimer Marina, et al. Gynecologic oncology 2016 4 (1) 101-7 - Lack of association between MTHFR C677T polymorphism and breast cancer risk in Ahvaz, west south-Iran.
Mohammadzadeh Ghorban, et al. Advanced biomedical research 2016 0 26 - Tier 1 Genomic Applications Toolkit for Public Health Departments
Disease: Multiple Diseases; Type: Tools; State: Multiple States - Prospective Case-Control Study to Evaluate the Role of Glutathione S Transferases (GSTT1 and GSTM1) Gene Deletion in Breast Carcinoma and Its Prognostic Significance.
Bansal Virinder Kumar, et al. The Indian journal of surgery 2015 12 (Suppl 3) 1067-72 - BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study.
Unni Sudhir K, et al. Journal of ovarian research 2016 0 (1) 18 - Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism.
Jafarzadeh A, et al. Cancer biomarkers : section A of Disease markers 2016 3 - Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.
King Tari A, et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 3 - Breast Cancer Risk Variants Affect Estrogen Receptor.
Cancer discovery 2016 3 - Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians.
Rizk Sherine M, et al. PloS one 2016 0 (3) e0151901 - Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphisms.
Street Christina M, et al. Xenobiotica; the fate of foreign compounds in biological systems 2016 3 1-10 - Association of the nibrin gene (NBN) variants with breast cancer.
Uzunoglu Hakan, et al. Biomedical reports 2016 3 (3) 369-373 - Polymorphisms of glutathione S-transferase ? 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility.
Al-Harras Mohammad F, et al. Oncology letters 2016 3 (3) 2182-2188 - TOX3 protein expression is correlated with pathological characteristics in breast cancer.
Han Cui-Cui, et al. Oncology letters 2016 3 (3) 1762-1768 - Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer.
Henouda Sarra, et al. Disease markers 2016 0 7869095 - Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer.
Kummar Shivaani, et al. Investigational new drugs 2016 3 - Genomic profiling of male breast cancer
TK Burki, Lancet Oncology, March 2016 - The cancer genetics and pathology of male breast cancer.
Deb Siddhartha et al. Histopathology 2016 Jan (1) 110-8 - A history of breast cancer and older age allow risk stratification of mammographic BI-RADS 3 ratings in the diagnostic setting.
Benndorf Matthias, et al. Clinical imaging 0 0 (2) 200-4
- Hot Topics (182)
- Genomics & Health Impact Scan (0)
- AMD Weekly Clips(1)
- HuGE (5122)
- AMD Weekly Clips (0)
- Weekly Scan (398)
- AMD Weekly Clips (0)
.png)
No hay comentarios:
Publicar un comentario